Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Nektar has a deep and diverse portfolio of investigational medicines in different stages of clinical development.
Nektar’s R&D pipeline of new investigational drugs includes treatments for cancer and auto-immune disease. We are developing novel immunotherapies, with the potential of harnessing key steps of the “Cancer Immunity Cycle”, in the fight against cancer. For more information please visit http://www.immunivation.com.
Products